A critical next step will be to determine how GLP-1 receptor agonists alter the absorption and systemic availability of alcohol, as pharmacokinetic changes may partially contribute to alcohol-related behavioral effects observed in both preclinical and clinical contexts
The degree of market acceptance of GB-102 or any product candidate for which we obtain marketing approval will depend on a number of factors, including: For example, even though we believe that GB-102 will have a longer duration of effect compared to approved treatments for wet AMD, it is possible that the market acceptance of GB-102, if it is approved for marketing, could be less than anticipated
Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells
NEW NATIONAL DATA SHOWS MORE KIDS AND YOUNG ADULTS ARE TURNING TO POPULAR WEIGHT LOSS
Reconstituted vial: NEVER freeze Freezing a reconstituted peptide solution causes ice crystal formation that physically disrupts the peptide's molecular structure
Results Safety All subjects completed the study